Navigation Links
Daily Low-dose Aspirin Can Prevent Heart Attack and Stroke But is Often Misused, from the January 2014 Harvard Heart Letter
Date:1/10/2014

Boston, MA (PRWEB) January 10, 2014

Aspirin is often hailed as a wonder drug, thanks to its ability to help stave off heart attacks and clot-caused strokes. But fewer than half of people who could benefit from a daily low-dose aspirin take it, while many others take it when they shouldn't, reports the January 2014 Harvard Heart Letter.

If you don't have heart disease, but do have high blood pressure, diabetes, or other risk factors for heart disease, don't automatically assume that taking aspirin every day is a good idea. "A lot of people take aspirin who really shouldn't," says Dr. Christopher Cannon, a cardiologist at Brigham and Women's Hospital and professor of medicine at Harvard Medical School. "Everyone assumes aspirin is harmless, but it isn't." For some, the downsides of aspirin—mainly gastrointestinal bleeding—outweigh its benefits.

Aspirin makes blood platelets less "sticky," and so less like to clump in the bloodstream, an early stage of blood clot formation. Most heart attacks happen when a clot blocks blood flow in a vessel that feeds the heart. Dampening the clot-forming process lowers the odds of a blockage.

At the same time, aspirin inhibits the formation of substances that protect the stomach's delicate lining. As a result, stomach upset or bleeding in the stomach and intestines can occur. Anyone taking daily low-dose aspirin who notices stomach irritation or upset should call his or her doctor, urges Dr. Cannon.

Taking aspirin with food may help. So can taking medications to treat heartburn, which help protect the stomach. These include simple antacids like Tums, acid blockers like famotidine (generic, Pepcid, Fluxid), or proton-pump inhibitors such as omeprazole (generic, Prilosec, Zegerid). A pill that combines aspirin and omeprazole may soon be available.

Before starting daily aspirin therapy, it's best to consult with a trusted doctor to weigh the risks and benefits. In addition to heart disease risk, important considerations include other health conditions, other medications taken, and even weight.

Read the full-length article: "Answers about aspirin".

Also in the January 2014 issue of the Harvard Heart Letter:

  •     Lower heart attack and stroke risk with a flu shot
  •     Health tips for former smokers
  •     Understanding cardiovascular pain

The Harvard Heart Letter is available from Harvard Health Publications, the publishing division of Harvard Medical School, for $20 per year. Subscribe at http://www.health.harvard.edu/heart or by calling 877-649-9457 (toll-free).

Read the full story at http://www.prweb.com/releases/2013/12/prweb11439139.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. LA BioMed study finds daily antibiotics most effective in preventing recurrent urinary tract infection
2. New Study Shows That Vitamin E May Benefit Alzheimer's Patients in Daily Activities and Savings In CareGiver Time
3. “Tips On How To Handle Difficult People,” A New Article on Vkool.Com, Gives Readers Ways to Improve Their Daily Relationships - V-kool
4. Omega Daily - The Natural Health Supplement Now Offers an Extra Discount on All Orders as a New Year Special at Slimmingbeauties.com
5. Battling the Annual Holiday Weight Gain Starts with Taking Your Daily Dose
6. Living with chronic pain: The daily struggle with a new self
7. Cyber Monday 2013 Smartphone, Tablet Deals – iPad Mini, Kindle, iPad Air, Nexus, Galaxy S4, Iphone 5 as Recommended by Daily News Deals
8. Renegade Diabetes Company DollarDiabetesClub.com Breaks Barriers to Glucose Testing; New Online Club Makes Daily Glucose Testing Affordable for Everyone
9. Water is the Top Adult Daily Beverage Choice, But Not So Much for Kids and Teens, Reports NPD
10. Therese Wilson’s "Fast Hidradenitis Suppurativa Cure" Reviewed by Daily Gossip Magazine
11. Natural Urticaria & Angiodema Treatment System by Dr Gary M. Levin Reviewed by Daily Gossip
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... , ... May 31, 2016 , ... WaterField Designs, an ... professionals, announces the waxed-canvas and leather Duo Dopp Kit , the ideal gift ... or ballistic nylon, the Duo is smartly designed for Dad’s grooming routine. ...
(Date:5/31/2016)... CA (PRWEB) , ... May 31, 2016 , ... Interest ... a primary screening tool and as an orthogonal tool for RNAi hit validation. A ... functional and specific guide RNAs—allows rapid generation of CRISPR RNA (crRNA) collections in arrayed ...
(Date:5/31/2016)... ... 2016 , ... MinerEye today announced that it has been ... by Gartner1 Inc. , Each year, Gartner identifies new Cool Vendors in key ... and their products and services. , According to Gartner, “Gartner's Cool Vendors in ...
(Date:5/31/2016)... ... May 31, 2016 , ... CURE Media Group ... cancer, has added Cancer and Careers to its Advocacy Spotlight ... on continuing successful careers while fighting cancer. , As partners, both organizations will ...
(Date:5/30/2016)... , ... May 30, 2016 , ... ... businesses, announced today the publication of an original infographic, " Health Benefits Reimbursement ... insurance professionals understand how Zane Benefits complies with various federal regulations and reforms. ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... 26, 2016   Change Healthcare , ... network solutions and technology-enabled services designed to ... into a strategic channel partnership with SourceMed, ... solutions and revenue cycle management services that ... rehabilitation clinics to optimize revenue, operational efficiency ...
(Date:5/25/2016)... FDA 510(k) clearance covers Confocal Miniprobes ... and surgical applications Mauna Kea Technologies ... multidisciplinary confocal laser endomicroscopy (CLE) platform, today announced ... the 12 th 510(k) clearance from United ... FDA clearance covers Confocal Miniprobes indicated for use ...
(Date:5/25/2016)... , Deutschland und GERMANTOWN, Maryland ... Zusammenarbeit mit Therawis bedient dringenden ... Brustkrebs   QIAGEN N.V. (NASDAQ: ... heute bekannt, eine Lizenz- und Entwicklungsvereinbarung mit Therawis ... für die Onkologie eingegangen zu sein. Ein erstes ...
Breaking Medicine Technology: